Kobo Biotech Limited (BOM:531541)
India · Delayed Price · Currency is INR 4.860
+0.230 (4.97%)
At close: Aug 21, 2026
Kobo Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 0.69 | 1.38 | 0.84 | 0.84 | 15.17 |
Short-Term Investments | 42.86 | 0.43 | 0.43 | 0.43 | 0.43 |
Cash & Short-Term Investments | 43.56 | 1.81 | 1.27 | 1.26 | 15.6 |
Cash Growth | 2311.79% | 42.20% | 0.47% | -91.90% | 1120.33% |
Accounts Receivable | 120.15 | 119.65 | 119.52 | 117.96 | 924.72 |
Other Receivables | - | - | - | - | 23.17 |
Receivables | 120.15 | 119.65 | 119.52 | 117.96 | 947.88 |
Inventory | 180.41 | 180.41 | 180.41 | 180.41 | 532.79 |
Prepaid Expenses | 0.08 | 0.06 | 0.1 | 0.13 | 0.26 |
Other Current Assets | 77.27 | 76.86 | 76.13 | 75.5 | 95.8 |
Total Current Assets | 421.45 | 378.78 | 377.43 | 375.26 | 1,592 |
Property, Plant & Equipment | 294.45 | 335.16 | 375.87 | 416.59 | 591.58 |
Long-Term Investments | - | - | - | - | 121.93 |
Other Long-Term Assets | - | - | - | - | -0 |
Total Assets | 715.9 | 713.94 | 753.3 | 791.85 | 2,306 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Accounts Payable | 569.04 | 557.81 | 547.35 | 521.72 | 604.51 |
Short-Term Debt | 597.59 | 597.59 | 597.59 | 597.59 | 1,747 |
Current Portion of Long-Term Debt | 482.19 | 482.19 | 474.23 | 474.23 | 522.68 |
Current Income Taxes Payable | 2.27 | 2.09 | 1.94 | 1.8 | 3.74 |
Other Current Liabilities | 81.41 | 38.56 | 37.74 | 37.78 | 113.37 |
Total Current Liabilities | 1,732 | 1,678 | 1,659 | 1,633 | 2,992 |
Long-Term Debt | 317.14 | 317.14 | 326.6 | 335.34 | 335.34 |
Long-Term Deferred Tax Liabilities | 29.9 | 29.9 | 29.9 | 29.9 | 29.9 |
Other Long-Term Liabilities | 17.77 | 17.77 | 17.77 | 17.77 | 21.08 |
Total Liabilities | 2,097 | 2,043 | 2,033 | 2,016 | 3,378 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Common Stock | 238.25 | 238.25 | 238.25 | 238.25 | 238.25 |
Additional Paid-In Capital | 317.05 | 317.05 | 317.05 | 317.05 | 317.05 |
Retained Earnings | -1,946 | -1,893 | -1,844 | -1,789 | -1,636 |
Comprehensive Income & Other | 9 | 9 | 9 | 9 | 9 |
Shareholders' Equity | -1,381 | -1,329 | -1,280 | -1,224 | -1,072 |
Total Liabilities & Equity | 715.9 | 713.94 | 753.3 | 791.85 | 2,306 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Total Debt | 1,397 | 1,397 | 1,398 | 1,407 | 2,605 |
Net Cash (Debt) | -1,353 | -1,395 | -1,397 | -1,406 | -2,590 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -56.80 | -58.56 | -58.64 | -59.01 | -108.70 |
Filing Date Shares Outstanding | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
Total Common Shares Outstanding | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
Working Capital | -1,311 | -1,299 | -1,281 | -1,258 | -1,399 |
Book Value Per Share | -57.98 | -55.79 | -53.72 | -51.39 | -45.00 |
Tangible Book Value | -1,381 | -1,329 | -1,280 | -1,224 | -1,072 |
Tangible Book Value Per Share | -57.98 | -55.79 | -53.72 | -51.39 | -45.00 |
Land | 23.65 | 23.65 | 23.65 | 23.65 | 23.65 |
Buildings | 188.59 | 188.59 | 188.59 | 188.59 | 188.59 |
Machinery | 816.84 | 816.84 | 816.84 | 816.84 | 1,704 |
Construction In Progress | - | - | - | - | 22.51 |